The European Respiratory Society spirometry tent: A unique form of screening for airway obstruction

European Respiratory Journal

Volumn 39, Issue 6, 2012, Pages 1458-1467

  Maio, Sara ^a   Sherrill, Duane L ^b   MacNee, William ^c   Lange, Peter ^d   Costabel, Ulrich ^e   Dahlén, Sven Erik ^f   Sybrecht, Gerhard W ^g   Burghuber, Otto C ^h   Stevenson, Robin ⁱ   Tønnesen, Philip ^j   Haeussinger, Karl ^k   Hedlin, Gunilla ^l   Bauer, Torsten T ^m   Riedler, Josef ⁿ   Nicod, Laurent ^o   Carlsen, Kai Håkon ^p   Viegi, Giovanni ^a,q  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d HVIDOVRE HOSPITAL   (Denmark)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f KAROLINSKA INSTITUTE   (Sweden)

^g SAARLAND UNIVERSITY   (Germany)

^h OTTO WAGNER HOSPITAL   (Austria)

ⁱ GLASGOW ROYAL INFIRMARY   (United Kingdom)

^j Dept of Pulmonary Diseases   (Denmark)

^k Lungen und Bronchialheilkunde Asklepios Fachkliniken   (Germany)

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^m Dept of Pneumology Respiratory Diseases Clinic Heckeshorn ^*  (Germany)

ⁿ Children's Hospital SchwarzachKardinal   (Austria)

^o LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^p UNIVERSITY OF OSLO   (Norway)

^q CNR   (Italy)

more..

Author keywords

Airway obstruction; General population; Global initiative for chronic obstructive lung disease criteria; Lower limit of normal criteria; Screening

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; PUBLIC HEALTH; QUESTIONNAIRE; RISK FACTOR; SCREENING TEST; SMOKING; SPIROMETRY;

ADULT; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; ASTHMA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SMOKING; SPIROMETRY; YOUNG ADULT;

EID: 84861872261     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00111910     Document Type: Article

References (41)

1. Celli BR, MacNee W, Augusti A, et al. Standard for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
2. Niederlander E. Cause of death in the EU. Statistics in focus - population and social conditions. Eurostat (European Communities) 2006; 101: 1-12.
3. World Health Organization. World Health Statistics 2008. www. who.int/whosis/whostat/2008/en/index.html. Geneva, World Health Organization. Date last accessed: March 6, 2012.
4. World Health Organization report 2007. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Geneva, World Health Organization.
5. European Respiratory Society/European Lung Foundation. European Lung White Book. The First Comprehensive Survey on Respiratory Health in Europe. Loddenkemper R, Gibson GJ, Sibille Y, eds. Sheffield, European Respiratory Society Journals, 2003.
6. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007; 370: 741-750.
7. Murtagh E, Heaney L, Gingles J, et al. Prevalence of obstructive lung disease in a general population sample: the NICECOPD study. Eur J Epidemiol 2005; 20: 443-453.
8. Lindberg A, Bjerg A, Rönmark E, et al. Prevalence and under-diagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006; 100: 264-272.
9. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63: 402-407.
10. Celli BR, Halbert RJ, Isonaka S, et al. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268-273.
11. Hwang YI, Kim CH, Kang H-R, et al. Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria. J Korean Med Sci 2009; 24: 621-626.
12. Silva GE, Sherrill DL, Guerra S, et al. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126: 59-65.
13. Viegi G, Matteelli G, Angino A, et al. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest 2004; 126: 1093-1101.
14. Arne M, Lisspers K, Ställberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med 2010; 104: 550-556.
15. Damarla M, Celli BR, Mullerova HX, et al. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care 2006; 51: 1120-1125.
16. Geijer RM, Sachs AP, Hoes AW, et al. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old. Fam Pract 2005; 22: 485-489.
17. Stav D, Raz M. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel. Isr Med Assoc J 2007; 9: 800-802.
18. Vandevoorde J, Verbanck S, Gijssels L, et al. Early detection of COPD: a case finding study in general practice. Respir Med 2007; 10: 525-530.
19. Zieliñski J, Bednarek M. Know the age of your lung study group. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119: 731-736.
20. Zielinski J, Bednarek M, Górecka D, et al. Increasing COPD awareness. Eur Respir J 2006; 27: 833-852.
21. Walters JA, Wood-Baker R, Walls J, et al. Stability of the EasyOne ultrasonic spirometer for use in general practice. Respirology 2006; 11: 306-310.
22. Menezes AMB, Perez-Padilla R, Hallal P C, et al. Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int J Tuberc Lung Dis 2008; 12: 709-712.
23. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
24. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
25. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
26. Global Initiative for Chronic Obstructive Lung Disease. Update 2009. www.goldcopd.org. Date last accessed: April 10, 2012.
27. Stratelis G, Jakobsson P, Molstad S, et al. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004; 54: 201-206.
28. Castillo D, Guayta R, Giner J, et al. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Respir Med 2009; 103: 839-845.
29. Van Durme YM, Verhamme KM, Stijnen T, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly. The Rotterdam study. Chest 2009; 135: 368-377.
30. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789-794.
31. De Marco R, Accordini S, Antò JM, et al. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European Community Respiratory Health Survey. Am J Respir Crit Care Med 2009; 180: 956-963.
32. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
33. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010; 65: 14-20.
34. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000; 117: Suppl. 2, 339S-345S.
35. Miller MR, Pedersen OF, Pellegrino R, et al. Debating the definition of airflow obstruction: time to move on? Eur Respir J 2009; 34: 527-528.
36. Langhammer A, Johnsen R, Gulsvik A, et al. Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag study. Eur Respir J 2001; 18: 770-779.
37. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60: 842-847.
38. 1/FVC <0.70 to detect airway obstruction? No. Chest 2010; 138: 1037-1040.
39. 1/ FVC <0.70 to detect airway obstruction? Yes. Chest 2010; 138: 1040-1042.
40. Bousquet J, Kiley J, Bateman ED, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010; 36: 995-1001.
41. MacNee W, Viegi G, Kamel N. New opportunities for respiratory research in Europe: FP7. Eur Respir J 2007; 29: 223-225.